ReviewImmunology letters2021
Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients.
Rasha Abu-Eid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it
ReviewImmunology letters2021
Rasha Abu-Eid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.